Titel	Veröffentlichungsdatum	Sprache	Zitate
Model Parameter Estimation and Uncertainty: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-6	2012/09/01	English	433
Modeling Good Research Practices—Overview: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-1	2012/09/01	English	411
Health-Related Quality of Life Measurement in Children and Adolescents: A Systematic Review of Generic and Disease-Specific Instruments	2008/07/01	English	397
Multiple Criteria Decision Analysis for Health Care Decision Making—An Introduction: Report 1 of the ISPOR MCDA Emerging Good Practices Task Force	2016/01/01	English	388
South Korean Time Trade-Off Values for EQ-5D Health States: Modeling with Observed Values for 101 Health States	2009/11/01	English	347
Recommendations on Evidence Needed to Support Measurement Equivalence between Electronic and Paper-Based Patient-Reported Outcome (PRO) Measures: ISPOR ePRO Good Research Practices Task Force Report	2009/06/01	English	346
Transferability of Economic Evaluations Across Jurisdictions: ISPOR Good Research Practices Task Force Report	2009/06/01	English	339
Incorporating the Patient's Perspective into Drug Development and Communication: An Ad Hoc Task Force Report of the Patient-Reported Outcomes (PRO) Harmonization Group Meeting at the Food and Drug Administration, February 16, 2001	2003/09/01	English	329
What Is Sufficient Evidence for the Reliability and Validity of Patient-Reported Outcome Measures?	2007/11/01	English	318
Estimating an EQ-5D-5L Value Set for China	2017/04/01	English	315
A Program of Methodological Research to Arrive at the New International EQ-5D-5L Valuation Protocol	2014/06/01	English	314
PROMIS® Adult Health Profiles: Efficient Short-Form Measures of Seven Health Domains	2019/05/01	English	314
Defining Elements of Value in Health Care—A Health Economics Approach: An ISPOR Special Task Force Report [3]	2018/02/01	English	301
Assessing the Direct Costs of Treating Nonvalvular Atrial Fibrillation in the United States	2006/09/01	English	298
Multiple Criteria Decision Analysis for Health Care Decision Making—Emerging Good Practices: Report 2 of the ISPOR MCDA Emerging Good Practices Task Force	2016/03/01	English	297
The KIDSCREEN-52 Quality of Life Measure for Children and Adolescents: Psychometric Results from a Cross-Cultural Survey in 13 European Countries	2008/07/01	English	297
State-Transition Modeling: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-3	2012/09/01	English	294
Pediatric Patient-Reported Outcome Instruments for Research to Support Medical Product Labeling: Report of the ISPOR PRO Good Research Practices for the Assessment of Children and Adolescents Task Force	2013/06/01	English	291
Model Transparency and Validation: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-7	2012/09/01	English	283
Recommendations for Evaluating the Validity of Quality of Life Claims for Labeling and Promotion	1999/03/01	English	280
Application of Rasch Analysis in the Development and Application of Quality of Life Instruments	2004/09/01	English	279
A Checklist for Retrospective Database Studies—Report of the ISPOR Task Force on Retrospective Databases	2003/03/01	English	274
The iMTA Productivity Cost Questionnaire	2015/09/01	English	270
Use of Existing Patient-Reported Outcome (PRO) Instruments and Their Modification: The ISPOR Good Research Practices for Evaluating and Documenting Content Validity for the Use of Existing Instruments and Their Modification PRO Task Force Report	2009/11/01	English	269
Rare Disease Terminology and Definitions—A Systematic Global Review: Report of the ISPOR Rare Disease Special Interest Group	2015/09/01	English	269
Matching-Adjusted Indirect Comparisons: A New Tool for Timely Comparative Effectiveness Research	2012/09/01	English	265
The Impact of Urinary Urgency and Frequency on Health-Related Quality of Life in Overactive Bladder: Results from a National Community Survey	2004/07/01	English	258
Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) Statement: Updated Reporting Guidance for Health Economic Evaluations	2022/01/01	English	256
The Direct Cost and Incidence of Systemic Fungal Infections	2002/01/01	English	255
Good Research Practices for Comparative Effectiveness Research: Defining, Reporting and Interpreting Nonrandomized Studies of Treatment Effects Using Secondary Data Sources: The ISPOR Good Research Practices for Retrospective Database Analysis Task Force Report—Part I	2009/11/01	English	250